Molecular and Cellular Biology · 2015 · 62 citations · 43 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionKidney CancerMalignant NeoplasmsRenal Cell CarcinomaSignal Transduction In CancerCancer Signaling PathwaysMatrix Metalloproteinase 1 GeneticsMatrix Metalloproteinase ModulationMatrix Metalloproteinase ProcessingRenal MalignancyTumor Cell MotilityTumor-associated Cytokines
We provide evidence that human SLFN5, an interferon (IFN)-inducible member of the Schlafen (SLFN) family of proteins, exhibits key roles in controlling motility and invasiveness of renal cell carcinoma (RCC) cells. Our studies define the mechanism by which this occurs, demonstrating that SLFN5 negatively controls expression of the matrix metalloproteinase 1 gene (MMP-1), MMP-13, and several other genes involved in the control of malignant cell motility. Importantly, our data establish that SLFN5 expression correlates with a better overall survival in a large cohort of patients with RCC. The inverse relationship between SLFN5 expression and RCC aggressiveness raises the possibility of developing unique therapeutic approaches in the treatment of RCC, by modulating SLFN5 expression.
43
Comprehensive molecular characterization of clear cell renal cell carcinoma
John A. Mengshol, Matthew P. Vincenti, Charles I. Coon et al. · Arthritis & Rheumatism · 2000 · 651 citations
Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11
Manqing Li, Elaine Kao, Xia Gao et al. · Nature · 2012 · 382 citations · Full text